Background: Residual renal function (RRF) affects sodium and fluid balance. The aim of this analysis was to examine the impact of RRF on the effect of a sodium-reduced peritoneal dialysis fluid (PDF) on blood pressure (BP).
Methods: This is a post-hoc analysis of a prospective, randomized, controlled double-blind clinical trial with 82 patients o n continuous ambulatory PD (CAPD) treated with a low-sodium (125 mmol/L Na) or a standard-sodium (134 mmol/L Na) PDF. Subgroups according to glomerular filtration rate (GFR) at baseline ( 6 mL/min/1.73 m(2)) were analyzed for BP and antihypertensive medication.
Results: In the low-GFR group on low-sodium PDF (N = 26), systolic BP was reduced from 152 +/- 24 mmHg at baseline to 137 +/- 21 mmHg at week 12, diastolic BP from 90 +/- 16 mmHg to 83 +/- 11 mmHg. In the low-GFR group on standard-sodium PDF and in the high-GFR group on both PDF types, only minor changes were observed. For the low-GFR subgroup, the confounder-adjusted mean study group difference in systolic BP at week 12 between low-sodium and standard-sodium PDF was -16.9 (95% confidence interval [CI] -27.2 to -6.6) mmHg, for diastolic BP, it was-7.0 (95% CI -12.6 to -1.4) mmHg. In both GFR subgroups, more patients had a reduced daily dose of antihypertensive medication and fewer patients an increased daily dose in the low-sodium compared with the standard-sodium group at week 12.
Conclusions: The reduction of BP with a sodium-reduced PDF seems to be more effective in patients with no or low RRF than in patients with residual capacity of renal sodium and fluid control.
- Fluid control
- antihypertensive medication
- SALT SENSITIVITY